Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279226 · ClinicalTrials.gov registry record · NA
Investigation of Radiofrequency Device for Treatment of Wrinkles and Rhytides
A NA study of Laxity of Skin, sponsored by Rocky Mountain Biosystems.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01279226 is a NA study of Laxity of Skin that has completed, run by Rocky Mountain Biosystems. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01279226, a NA study of Laxity of Skin, has completed, sponsored by Rocky Mountain Biosystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device intended to be used to improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
Conditions Studied
Interventions
- DEVICE Auralevée device
Study Locations (1)
Washington
- Laser Treatment Center - Kirkland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01279226
The ClinicalTrials.gov registry entry for NCT01279226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rocky Mountain Biosystems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Laxity of Skin appearing as the primary indexed condition, and to 1 intervention - of which Auralevée device is the first listed.
NCT01279226 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01279226 about?
NCT01279226 is a clinical study titled "Investigation of Radiofrequency Device for Treatment of Wrinkles and Rhytides". The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device intended to be used to improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
What is the current status of trial NCT01279226?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-02. Estimated completion is 2011-02.
What conditions does trial NCT01279226 study?
This clinical trial studies the following conditions: Laxity of Skin.
What interventions are being tested in trial NCT01279226?
The interventions under investigation include: Auralevée device (DEVICE).
Who is sponsoring clinical trial NCT01279226?
This trial is sponsored by Rocky Mountain Biosystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01279226 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.